From: Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study
Hazard ratio
95% CI
P
Steroids during VAP
1.93
1.25-2.98
<0.01
Cirrhosis
3.72
1.83-4.31
Age
1.02
1.01-1.04
SAPS II
SOFA day 1
1.15
1.07-1.23
Statin prior exposure
1.23
0.79-1.90
0.36